Pharmaceutical Technology on MSN

CIPO grants patent to Palisade Bio’s PALI-2108

Patent number 3,174,137, which is titled Gut Microbiota Bioactivated PDE4 Inhibitor Precursors, encompasses the composition ...
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical ...
Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.
This is the result of work carried out by researchers at the Università Cattolica del Sacro Cuore/Fondazione Policlinico Universitario A. Gemelli IRCCS at Rome in collaboration with the University of ...
Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...
Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...
When: The CMMC final rule went into effect in December 2024 and will start appearing in contracts at the end of 2025. Why it matters: The Defense Department is on the cusp of implementing the ...
Joyce Echaquan died because she was Indigenous. Those were her grieving husband's words from a statement he delivered to a crowd of journalists on Oct. 5, 2021, reacting to the release of a coroner's ...
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/− Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability–High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data ...